The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Abstract Details
Activity Number:
|
641
|
Type:
|
Invited
|
Date/Time:
|
Thursday, August 4, 2011 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #300491 |
Title:
|
Sensitivity of Tests and Estimates in Depression Trials when Sophisticated Imputation Techniques Are Used
|
Author(s):
|
Craig Mallinckrodt*+
|
Companies:
|
Eli Lilly and Company
|
Address:
|
Lilly Corporate Center, Indianapolis, IN, 46285,
|
Keywords:
|
sensitivity ;
imputation ;
missing data
|
Abstract:
|
The National Research Council was commissioned by FDA to make recommendations on the prevention and treatment of missing data in clinical trials. The Panel's report was made public in late 2010. This presentation will include a brief review of the rational behind the Panel's recommendations. However, the main focus will be on a case study from a clinical trial in depression to illustrate the Panel's recommendations for handling missing data from continuous endpoints. Specifically, the robustness of the a priori specified likelihood-based primary analysis will be assessed using a variety of MNAR analyses and an inclusive modeling multiple imputation approach, along with influence and residual diagnostics for the primary analysis. A novel method of imputing missing data for both the drug and placebo groups from the placebo group will be presented both as a likely conservative MNAR analysis and as an alternative to BOCF to assess effectiveness.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2011 program
|
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.